Clinical Trials Browser

Phase 1 × Rhabdomyosarcoma × Everolimus × Clear all

NCT00187174 2015-03-04

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Phase 1 Completed

Brain Neoplasms, Neoplasms, Recurrence, Rhabdomyosarcoma, Sarcoma